Hyperpolarization methods for MRS by Goodson, Boyd M. et al.
Hyperpolarization Methods for MRS 
 
Boyd M. Goodson, Nicholas Whiting, Aaron M. Coffey, Panayiotis Nikolaou, Fan Shi, 
Brogan M. Gust, Max E. Gemeinhardt, Roman V. Shchepin, Jason G. Skinner, Jonathan R. 
Birchall, Michael J. Barlow, Eduard Y. Chekmenev* 
 
Boyd M. Goodson 
Southern Illinois University, Department of Chemistry and Biochemistry 
Carbondale, IL, 62901, United States 
 
Nicholas Whiting 
The University of Texas MD Anderson Cancer Center, Department of Cancer Systems 
Imaging 
Houston, TX, 77030, United States 
 
Aaron M. Coffey 
Vanderbilt University, Institute of Imaging Science (VUIIS), Department of Radiology 
Nashville, TN, 37232, United States 
 
Panayiotis Nikolaou 
Vanderbilt University, Institute of Imaging Science (VUIIS), Department of Radiology 
Nashville, TN, 37232, United States 
 
Fan Shi 
Southern Illinois University, Department of Chemistry and Biochemistry 
Carbondale, IL, 62901, United States 
 
Brogan M. Gust 
Southern Illinois University, Department of Chemistry and Biochemistry 
Carbondale, IL, 62901, United States 
 
Max E. Gemeinhardt 
Southern Illinois University, Department of Chemistry and Biochemistry 
Carbondale, IL, 62901, United States 
 
Roman V. Shchepin 
Vanderbilt University, Institute of Imaging Science (VUIIS), Department of Radiology 
Nashville, TN, 37232, United States 
 
Jason G. Skinner 
University of Nottingham, School of Medicine 
Nottingham, NG7 2UH, UK 
 
Jonathan R. Birchall 
University of Nottingham, School of Medicine 
Nottingham, NG7 2UH, UK 
 
Michael J. Barlow 
University of Nottingham, School of Medicine 
Nottingham, NG7 2UH, UK 
 Eduard Y. Chekmenev* 
Vanderbilt University, Institute of Imaging Science (VUIIS), Department of Radiology, 
Department of Biomedical Engineering, Department of Biochemistry, Vanderbilt-Ingram 
Cancer Center (VICC) 
Nashville, TN, 37232, United States 
1161 21st Ave South 
MCN AA-1105 
Nashville, TN 37232, United States 
E-mail: eduard.chekmenev@vanderbilt.edu 
Phone: 615-322-1329 
Fax: 615-322-0734 
Short Biographies: 
Boyd Goodson graduated from Princeton University in 1995 and earned his PhD in chemistry 
in 1999 with Alexander Pines at U.C. Berkeley. Following postdoctoral work with Ahmed 
Zewail at Caltech, in 2002 Goodson joined the faculty at Southern Illinois University 
Carbondale and was promoted to full professor in 2014. Goodson’s research interests concern 
NMR/MRI sensitivity enhancement and hyperpolarization. 
Nicholas Whiting, b1983. PhD (supervisor Prof. Boyd Goodson) 2010, Southern Illinois 
University, Carbondale, IL, USA. NSF International Research Fellow at the University of 
Nottingham, UK (with Dr. Michael Barlow and Prof. Peter Morris). Odyssey and NCI Cancer 
Prevention Fellow (with Prof. Pratip Bhattacharya) at UT MD Anderson Cancer Center. 
Aaron M. Coffey, PhD 2014, Vanderbilt University, Nashville, TN, USA. Postdoctoral 
Fellow at Vanderbilt University Institute of Imaging Science (with Prof. Eduard Y. 
Chekmenev). Co-authored >30 peer-reviewed articles covering advanced MR detection 
hardware and utilizing hyperpolarization techniques to enable MR contrast agents for in vivo 
molecular imaging for improved human health. 
Panayiotis Nikolaou, b1978, PhD (supervisor Prof. Boyd Goodson) 2010, Southern Illinois 
University, Carbondale, IL, USA. Currently: Post-Doctoral Fellow, Vanderbilt University, 
Nashville, TN USA (with Dr. Eduard Chekmenev) at the Institute of Imaging Science. 
Fan Shi. After graduating with BS/MS degrees from Zhengzhou University (China), he 
joined the Goodson Lab at SIUC (USA) in 2011. His research has concerned the 
development and application of SABRE catalysts—particularly under heterogeneous 
conditions ("HET-SABRE"). Fan graduated with a PhD in 2015, and is now an intern with 
Cabot Labs in Chicago, IL. 
Brogan Gust graduated with a B.S. degree in chemistry from Southern Illinois University 
Carbondale in 2013. While at SIUC, he was under the guidance of Boyd Goodson 
researching NMR enhancement using Xenon-129 hyperpolarization. 
Max Gemeinhardt joined the Goodson Lab at SIUC in 2011 as undergraduate working on 
pH-sensing SPIONs. He graduated in 2012 with a B.S. degree and is currently pursuing a 
M.S. degree at SIUC in the Goodson Lab, where his current research interests include 
cryptophane host-guest inclusion complexes and SABRE NMR enhancement. 
Roman V. Shchepin, b1978, PhD (Prof. Patrick Dussault) 2006 in University of Nebraska-
Lincoln (Lincoln, NE). Postdoctoral Fellow at Vanderbilt University Department of 
Chemistry (2007-2009) with Prof. Ned A. Porter and VUIIS (2010-2013) with Prof. Eduard 
Y. Chekmenev. He is currently Research Instructor at VUIIS with main focus on the 
chemistry of hyperpolarized NMR/MRI. Coauthored >30 peer-reviewed original research 
publications. 
Jason G. Skinner. b1989. M.Phys., 2012. PhD research student (supervisors: Prof. I. Hall, 
Prof. P. Morris, Dr. M. Barlow), University of Nottingham, UK. Research interests include 
spin-exchange optical pumping, hyperpolarised noble gas lung MRI, and disease detection 
via exhaled volatile organic compounds. 
Jonathan R. Birchall, b1991, M.Phys., 2013, PhD research student (supervisors: Prof. I. Hall, 
Dr. M. Barlow, Prof. J. Owers-Bradley), University of Nottingham, UK. Research interests 
include development and analysis of Spin-Exchange Optical Pumping techniques for 
functional human lung imaging. 
Michael J. Barlow, b1958, PhD (Supervisor Prof. Brian Ridley FRS) 1988 University of 
Essex, UK. Postdoctoral Fellow at MOD Malvern, Durham University, Surrey University, 
Imperial College London and Rutherford Appleton Lab, Oxford. Instrument Manager - MAG 
team NASA Cassini Mission. Faculty Fellow University of Nottingham. Co-authored >20 
peer-reviewed publications in the areas of semiconductor physics, space physics, solid state 
NMR, laser physics and hyperpolarized MRI. 
Eduard Y. Chekmenev, b1977, PhD (supervisor Prof. Richard J. Wittebort) 2003, University 
of Louisville, KY, USA. Postdoctoral Fellow at NHMFL, Tallahassee, FL, USA (with Prof. 
Timothy Cross) and at Caltech (with Prof. Daniel P. Weitekamp) and HMRI (with Dr. Brian 
D. Ross). Co-authored >70 peer-reviewed original research publications in the areas of solid-
state NMR of proteins and hyperpolarized NMR/MRI. Research interests include 
development of methods of hyperpolarization for Biomedical applications. 
 
Keywords: Hyperpolarization, DNP, PHIP, Parahydrogen, Xenon, SABRE, Carbon-13, 
SEOP. 
  
Abstract 
This chapter covers the fundamental principles and practice of NMR hyperpolarization 
techniques, which are proving useful for in vivo Magnetic Resonance Spectroscopy (MRS) 
studies of metabolism in animal models, and clinical trials with hyper-enhanced sensitivity. 
Fundamentally, hyperpolarization methods enhance nuclear spin polarization by orders-of-
magnitude, resulting in concomitant improvement in NMR detection sensitivity. The 
hyperpolarization methods described here—Dynamic Nuclear Polarization (DNP), 
Parahydrogen Induced Polarization (PHIP), Signal Amplification By Reversible Exchange 
(SABRE) and Spin-Exchange Optical Pumping (SEOP)—are capable of achieving nuclear 
spin polarization approaching the theoretical maximum of unity on nuclear spin sites of 
molecular or atomic agents suitable for in vivo administration. Importantly, hyperpolarization 
is inherently non-equilibrium in nature: the duration of the hyperpolarization is frequently 
short-lived, being limited by the in vivo spin-lattice relaxation times (T1) which are on the 
order of seconds to a minute. Nevertheless, sufficient amounts of nuclear spin polarization 
can survive the process of preparation, administration, and in vivo circulation to provide 
extraordinary enhancement of the hyperpolarized agent. The chemical shift dispersion of 
these agents at the molecular location of interest reports on functional, metabolic and other 
processes at the molecular level, enabling true molecular MRS imaging. 
  
1. INTRODUCTION 
The sensitivity and signal-to-noise ratio (SNR) of the Nuclear Magnetic Resonance 
(NMR) experiment is directly proportional to the nuclear spin polarization factor P, which 
represents the fraction of the alignment of the nuclear spin ensemble with an applied 
magnetic field B0. In conventional NMR, P ≈ għB0/2kT under thermal equilibrium conditions 
governed by the Boltzmann distribution (with g= the gyro magnetic ratio; ħ=Plank’ s 
constant/2π; k=Boltzmann’s constant; and T=absolute temperature). In vivo conditions imply 
temperatures in excess of 300 K. As a result, even if a high-field magnet—e.g. a 3 Tesla (T) 
clinical MRI scanner—is employed for magnetic resonance (MR) spectroscopy (MRS), the 
value of P of proton (1H) and carbon-13 (13C) nuclear spins is only 1´10-5 and 2.5´10-6 
respectively. Therefore, the vast majority of the nuclear spin ensemble does not in fact 
contribute to the NMR signal. For this reason, NMR in general and MRS in particular are 
frequently considered insensitive probes. 
However, P can be artificially increased significantly relative to the thermal equilibrium 
level, via a process called NMR hyperpolarization. Several hyperpolarization techniques 
realize enhancements of P by several orders-of-magnitude over the Boltzmann level, and 
allow P to approach the theoretical maximum of unity. The corresponding enhancement 
factor, e, is field-dependent and defined as a ratio of P in the hyperpolarized (HP) state to that 
in the thermal-equilibrium state (e.g. e = 104 to 105 for 13C at 3 T).1 
The fundamental concept of NMR hyperpolarization and its use in MRS is attractive 
because it offers extraordinary advantages over conventional MRS.2 First, the SNR can be 
significantly improved even using much lower concentrations of detected compounds than 
are present endogenously. Second, the data acquisition time can be dramatically decreased 
from tens of minutes down to sub-second scans. Third, an HP contrast agent (HCA) entering 
the biological system (i.e., excised organ, living organism, etc.) and reporting on metabolic 
functional events can provide insightful dynamic information on in vivo metabolism in real 
time compared to the static picture typically obtained with conventional single or multi-voxel 
MRS. Not surprisingly, biomedical applications represent the major driving force behind the 
fields of NMR hyperpolarization and HCA development, owing to their potential for 
revolutionizing medical diagnostics, drug therapy development, and probing physiological 
mechanisms. 
However, HP NMR techniques are no panacea, as they have inherent disadvantages and 
shortcomings that must frequently be confronted during HCA production. First, HCAs are 
nearly always prepared exogenously in a hyperpolarization apparatus, frequently requiring 
sophisticated and expensive hardware. Second, HCAs must retain a HP state sufficiently long 
for quality assurance, transport, administration, in vivo delivery and NMR/MRS 
measurement. These requirements limit the number of molecular sites (i.e. moieties of 13C, 
15N, 129Xe, etc.) suitable for HP MRS, to those whose spin lattice relaxation times (T1) are 
long enough to accomplish all this. Finally, the decay of the HP state to thermal equilibrium 
is irrecoverable. Therefore, signal acquisition must be fast and efficient to account for 
polarization losses via T1 relaxation, RF pulsing (for detection), and the effects of in vivo 
metabolism and dilution.3 
This chapter describes four hyperpolarization techniques: (1) Dynamic Nuclear 
Polarization (DNP), (2) Parahydrogen Induced Polarization (PHIP), (3) Signal Amplification 
By Reversible Exchange (SABRE) and (4) Spin-Exchange Optical Pumping (SEOP) of 
129Xe. These techniques have already proven effective for preparing HCAs that can be used 
for tracking metabolic and functional processes in vivo (see emrstm12533), because they are 
capable of achieving P approaching the theoretical maximum of unity on nuclear spin sites of 
molecular or atomic HCAs. Moreover, the HCAs for MRS fundamentally offer a wide 
dynamic range of chemical shift dispersions either through metabolism (e.g. 13C metabolites) 
or by their sensitivity to the local environment (e.g. 129Xe). Many HCAs have been validated 
in animal models,2 while some HCAs (e.g. HP 13C-pyruvate and 129Xe) are being tested in 
clinical trials.4 
The primary focus in this chapter is on the fundamentals of these hyperpolarization 
techniques (i.e. how they are generated and their physical and chemical properties), their 
existing or emerging MRS relevance and a description of the hyperpolarization equipment 
(frequently referred to as hyperpolarizers) required to perform these techniques. Accordingly, 
the chapter describes and cites only selected works in these areas, and the reader may 
additionally benefit from some recent comprehensive reviews.2, 5-9 
2. DYNAMIC NUCLEAR POLARIZATION (DNP) 
2.1 Fundamentals 
Despite the demonstration by Overhauser in the early 1950s of the underlying basis of 
DNP—that P could be enhanced by cross-relaxation with nearby electrons due to differences 
in their gyromagnetic ratios (ge/gI ~660)—only recently has interest in its potential 
applications for biomedical MRI and MRS emerged.10 While various methods fall under the 
DNP umbrella, the “dissolution DNP” (d-DNP) method is the most commonly used method 
for in vivo applications.1, 9 In biological d-DNP MRS experiments, the general preparation 
procedure involves: (i) mixing the MR-active species of interest with a paramagnetic source 
of free electrons; (ii) placing the mixture in a high magnetic field at low cryogenic 
temperatures; (iii) subsequent irradiation with a microwave source resonant on the electron 
spin resonance (ESR) frequency to mediate the transfer of electron polarization to nearby 
nuclei11 followed by (iv) rapid sample thawing using a hot solvent to warm the frozen 
polarized sample and transfer to the MR scanner for in vivo injection as a liquid. These 
conditions generate electron spin polarizations that can approach unity as shown in Figure 1, 
with a significant fraction of the prepared P largely surviving the rapid dissolution in step 
(iv). 
<Figure 1 near here> 
<Figure 2 near here> 
 
2.2 Dissolution DNP (d-DNP) Instrumentation 
Both commercial and home-built d-DNP devices have been extensively used for in vivo 
MRS. While each polarizer design may have unique characteristics, they are all comprised of 
the same basic components: a superconducting magnet that provides a B0  of 3-7 T, a liquid 
helium cryostat for sample cooling to 1-4 K, a microwave source to transfer polarization from 
the electrons to nuclei (~100 mW), and a mechanism that rapidly dissolves the frozen sample 
pellet and delivers the solution for collection.9 Step (i) of the typical d-DNP experiment 
proceeds as follows: the species of interest is mixed with a radical source and a glassing 
agent in a typically flat sample container (up to a few hundred m L) and lowered into the 
cryostat, as depicted in Figure 2. There in step (ii), the sample is frozen into an amorphous 
solid at low temperatures either by submersion into a liquid helium bath (where vacuum-
pumping reduces the vapor pressure, and hence bath temperature) or by exposure to a stream 
of continuously flowing liquid helium. The microwave source, whose frequency is set to the 
ESR line of the chosen radical species at the B0 of the polarizer (typically within ~80-140 
GHz, with a ~0.5 GHz sweep range), irradiates the sample for ~1 hr in step (iii), using an 
antenna that takes advantage of the large flat surface area of the sample container. An on-
board NMR system can check the HP signal while sweeping the microwave source to allow 
for optimization of the microwave frequency and excitation power (Figure 1c), and for 
monitoring the build-up of hyperpolarization over time (Figure 1d). 
Step (iv) of the procedure requires a superheated solvent with high heat capacity, which is 
typically satisfied by pH-buffered saline. This is injected into the sample cup inside the 
cryostat. The lifetime of the HP signal is determined by the T1 of the HCA, so to mitigate P 
losses, the rapid dissolution is performed at high B0 to minimize the sudden depolarizing 
effects of the paramagnetic centers as the temperature rises above ~4 K. Dissolution also 
reduces the relative concentration of radicals and lowers their contribution to the nuclear spin 
relaxation rate9 as the sample volume expands by an order of magnitude (this process also 
dilutes the HP agent). The room-temperature (RT) T1 values of most HCAs used for 
biomedical MRS are ≤ 1 min but B0 changes between the polarizer and MR scanner may 
further reduce T1. Rapid shuttling of the sample from the polarizer to the scanner is key, and 
is typically performed pneumatically using helium gas through small diameter tubing. There, 
the polarized solution is quickly filtered to remove persistent radicals using anion-exchange 
or polyethylene filters9 and injected into the subject (Figure 2). 
A commercially available d-DNP device for clinical use has recently been developed 
(SPINlab; GE Healthcare) that operates at 5 T and 1.1 K.12 The system uses an on-board 
helium recycling system that dramatically lowers the consumption of liquid helium, which is 
expensive. While many other features of its design and operation are similar to that described 
above, additional quality-control steps are incorporated to ensure that the injectable solution 
meets clinical criteria for pH, temperature, P value, sterility, purity and residual radical specie 
concentration. In general, the larger sample volumes required for human use necessitate 
longer dissolution, transport, quality-control, and injection periods, such that significant time 
(e.g. >65 s) may elapse between the initial dissolution and final injection. Nevertheless 
typical 13C P values are ~15-20% after quality control, which is certainly sufficient to 
perform HP MRI/MRS in human patients with great advantage vs. conventional MRS with P 
~10-3 %.4 
2.3 Common HP agents produced with d-DNP 
2.3.1 13C-labelled small biomolecules 
The overall P, T1, and biological relevance of the agent are the main criteria for choosing 
a HP species for MRS applications. Further considerations include the ability to form a glassy 
matrix in a sufficiently high concentration to mitigate dilution effects from the dissolution 
step; sufficient chemical shift range to differentiate the primary polarized species from any 
downstream products; the cost of isotopic enrichment; the ability to lessen the depolarization 
effects of nearby protons via deuteration;13 and toxicity. While a number of MR-active nuclei 
are eligible for DNP, the most commonly pursued are 13C-labelled carboxyl sites of 
metabolites. Of the latter, 13C-pyruvate has garnered the most attention because of its 
relatively high P values (>50 %), long T1 (~60 s), and ability to probe the tricarboxylic acid 
(TCA) cycle and glycolysis within a T1-relevant timescale.14 Additional notable 13C-labelled 
small molecules pursued for DNP studies include urea,1 fumarate, glutamine, fructose, 
lactate, glucose, diethyl succinate, and acetate.2, 13 
2.3.2 Extension to other nuclei 
Beyond 13C, the most commonly pursued d-DNP species for MRS studies are biologically 
relevant 15N-labelled compounds, such as urea and choline. However, despite some benefits 
(the T1 of 15N-choline ~4 min),13 the lower gyromagnetic ratio makes 15N MRS more 
challenging for achieving useful signal intensities and gradient strengths for spatial 
localization with typical scanner hardware. Other species that can be hyperpolarized by DNP 
and may have potential for future in vivo applications include: 1H, 6Li, 29Si, 31P, 89Y, 107Ag, 
and 129Xe. 
2.3.3 Secondary and co-polarization 
The enhanced signal from isotopically labeled HP small molecules may be translated into 
their chemical reaction products. This process, referred to as secondary polarization, allows 
the study of biologically relevant molecules that may not polarize well on their own, but have 
metabolic predecessors that do. This process can either be enzymatically regulated, such as 
with [1,1-13C2]acetic anhydride breaking into different [1-13C]N-acetylated amino acids,13 or 
non-enzymatically regulated—for instance, the reaction of 1,2-13C-pyruvate with H2O2 to 
form 13CO2, 13C-acetate, and 13C-bicarbonate.15 Co-polarization of a single “batch” of 
different small molecules using d-DNP during agent production allows the simultaneous 
study of different biophysical parameters and processes such as pH, metabolism, necrosis, 
and perfusion.13 While the commingled molecules’ solid-state polarization P and T1 values 
are often similar to their individual values, drawbacks include lower concentrations of, and 
potential interactions among, the small molecules involved. 
2.4 Radicals and Glassing Agents 
2.4.1 Choice of radical species 
The build-up time and hyperpolarization level for all species are highly dependent on the 
choice of radical used to mediate the DNP. Typical radical concentrations range from 15-60 
mM, and may persist post-thawing, requiring filtering before administration. The most 
widely used sources of free electrons for 13C DNP have been the trityl and 1,3-
bisdiphenylene-2-phenylallyl (BDPA) radicals. Because their ESR lines are narrower than the 
1H resonance frequency dispersion, the probability of cross-polarization with 1H is lowered, 
which increases the chances of polarizing nearby 13C nuclei. 
Further improvements in the P level and reductions in buildup time can be gained by the 
addition of a Gd3+ complex to the trityl radical solutions. The highly efficient electron-1H 
cross-polarization of nitroxyl radicals (e.g., TEMPO;	2,2,6,6-tetramethylpiperidine-1-oxyl) 
can also be used in conjunction with a 1H-13C cross-polarization scheme to decrease 13C 
polarization time, albeit with lower overall 13C polarization compared to trityl or BDPA 
radicals. Liquid-state P can be further increased using a deuterated solvent for the nitroxyl 
radicals.9 Additional gains have been reported using bi-radicals comprised of two TEMPO 
radicals tethered by a polyethylene chain.16 
2.4.2 Choice of glassing agent 
The DNP process is most efficient when the HP molecule is homogenously mixed with 
the radical species and formed into a glass, as already noted. This amorphous state allows the 
paramagnetic centers to achieve close contact with nearby nuclei, which is not the case in a 
crystalline lattice. Typical glassing agents include glycerol and dimethyl sulfoxide (DMSO), 
which act to prevent crystallization. Some HP molecules such as neat 13C-pyruvate, are 
capable of self-glassing17, which allows for a higher concentration of 13C nuclei that speeds 
13C spin diffusion resulting in a more homogenously-polarized sample.18 
2.5 DNP Advantages, Limitations, and Future Prospects 
As a hyperpolarization method, DNP’s versatility lies in its ability to hyperpolarize a 
variety of biologically relevant molecules not easily polarized by other methods. Target 
molecules can achieve high P with sufficiently long T1 values for probing metabolic 
pathways, and clinical trials are already underway for HP 13C-pyruvate. The main limitations 
thus far are the high cost of purchase, maintenance, and infrastructure required for the 
polarizers. Improvements in cryogen recovery and solid-state cooling can lower operational 
costs, and further optimization of the physical and chemical environment of the HP species 
should improve P and T1 values, as would the ability to store the enhanced polarization in a 
singlet state until it is ready for MRS applications. Finally, the demonstration of a clinically 
important application of HP MRI—such as using 13C-pyruvate to study prostate cancer or 
heart dysfunction—will greatly hasten the development of all d-DNP aspects.9 
3. PARA-HYDROGEN (para-H2) PRODUCTION 
In addition to its more recent applications in HP MRS, the properties of para-hydrogen 
(para-H2) have proved important for hydrogen’s use as a rocket fuel by minimizing boil-off 
due to state conversion, and even earlier, para-H2 served as a prototypical system during the 
development of quantum theory. The di-hydrogen molecule possesses two nuclear spin 
isomers, denoted as “ortho-“ and “para-“ states, comprised of a nuclear triplet state and a 
singlet state, respectively. Importantly, while representing the simplest nuclear singlet state, 
para-H2, per se, has net spin I = 0 and is therefore NMR invisible. As will be seen in the 
following sections, its use in NMR/MRS is as an extremely powerful vector for transferring 
HP to HCAs of interest. For further discussion of the physics of parahydrogen, we direct the 
interested reader to the books by Farkas on hydrogen19 and Linus Pauling on quantum 
mechanics20, and the review by Green and co-workers.5 
Inter-conversion of ortho-hydrogen (ortho-H2) to para-H2 (with a heat of conversion of 
670 J/g) is forbidden according to the selection rules of quantum mechanics. It thus occurs 
very slowly. Spontaneous emission of radiation was calculated by Wigner to result in a 
conversion rate of ~10-10 sec-1, or approximately one transition per 1 gram every three 
hundred years.19 In 1930, Hall and Oppenheimer calculated that molecular collisions at 
atmospheric pressure result in a rate of one per ~108 sec/1 g for the ortho-para transition half 
lifetime, or about 3 years.19 While such a slow inter-conversion rate is nominally unfavorable 
to para-H2 production, Bonhoeffer and Harteck discovered in 1929 that paramagnetic 
catalysts, including for example, activated charcoal, nickel, and hydrated iron-III oxide, 
greatly accelerate the establishment of thermodynamic equilibrium for the ratio of ortho-
H2/para-H2. 
<Figure 3 near here> 
The instrumentation used to generate high-purity para-state dihydrogen is commonly 
called a “parahydrogen generator,” shown in Figure 3. The essential purpose of the generator 
is to pass bulk H2 at RT (i.e. ~293 K) over a paramagnetic catalyst at a cryogenic temperature 
of ~20 K to rapidly equilibrate the 75% ortho-H2 fraction to the lower-temperature 
Boltzmann thermal equilibrium, thereby creating para-H2 with nearly 100% para-fraction. 
Typically, the gas flows through a catalyst chamber attached to a two-stage, Joule-Thomson 
effect, helium cryocooler cold-head. The flow is regulated with either: (i) flow restrictors 
such as mass flow controllers, snubbers, or needle valves;21, 22 or (ii) by releasing small 
batches of compressed H2 between automatically-sequenced solenoid valves.23 After 
separation of the para-H2 from the catalyst and subsequent storage at RT, quantum-
mechanical symmetry selection rules forbid re-establishment of the RT equilibrium. Provided 
the para-H2 storage vessel contains no paramagnetic impurities (as is the case for those glass-
lined or of aluminum, although the absence of O2 is also important), the relaxation rate of the 
para-hydrogen back to the RT equilibrium can be on the order of months.21-23 Thus para-H2 
experiments are possible long after production. 
 
4. PARA-HYDROGEN INDUCED POLARIZATION (PHIP) 
4.1 Fundamentals 
While the para-H2 molecule is itself NMR invisible, Bowers and Weitekamp24 have 
demonstrated that the para-H2 singlet can be unlocked via the chemical reaction of 
hydrogenation provided that the para-H2 is added in a pairwise manner (best exemplified in 
the molecular mechanism of H2 addition), and that the nascent protons in the resulting 
hydrogenation product are no longer magnetically equivalent. This phenomenon of symmetry 
breaking the para-H2 nuclear singlet state via hydrogenative processes is termed 
“parahydrogen induced polarization” (PHIP).25 
<Figure 4 near here> 
While the para-H2 singlet can be preserved for weeks and months, once the symmetry is 
broken and the para-H2 pair is incorporated into the molecular framework of a product 
molecule (Figure 4), the relaxation decay processes (via T1 and the spin-spin relaxation time, 
T2) are significantly more efficient (on a time-scale of seconds)—leading to rapid 
depolarization. For the majority of metabolically relevant injectable contrast agents that can 
be envisioned, fast T1 relaxation limits any meaningful preparation of HCA for biomedical 
use. 
This initial fundamental PHIP challenge was overcome in the early 2000s, when an 
adjacent 13C carboxyl (and potentially 15N or others) with significantly longer T1 was 
introduced by Golman26 and Goldman.27 In addition, deuteration of the PHIP molecular 
precursor can extend the T1 lifetime of the nascent protons, which has proven especially 
useful in PHIP of gases.28 In the PHIP process, polarization from nascent para-H2 protons is 
efficiently transferred to the 13C nucleus via the network of J-couplings using either magnetic 
field-cycling or radiofrequency (RF) pulse-based methods. Regardless of the approach used, 
the chemical reaction between para-H2 and the unsaturated substrate molecule must be 
performed on a relatively fast time scale (seconds), i.e. significantly shorter than the effective 
relaxation times of the nascent para-H2 protons, in order to minimize polarization losses 
during the reaction. Post-reaction, the polarization is typically transferred to the 13C nucleus 
within a second. Moreover, even in the case of RF-based polarization transfer, which has 
proven to be more efficient, as gauged by the %P delivered to 13C, to date, the PHIP method 
is relatively low cost because the PHIP process can be performed at very low magnetic fields 
(a few mT) using relatively simple NMR hardware. 
4.2 Molecular Precursors and Contrast Agents 
The design of PHIP precursor molecules for biomedical applications and MRS is a 
challenging process that must meet critical requirements. In particular, the molecule must 
possess an unsaturated (typically C=C) bond adjacent to 13C to provide a J-coupling contact 
between the nascent para-H2 protons and the 13C to enable efficient polarization transfer. 
Furthermore, the efficiency of this polarization transfer in RF pulse-based polarization 
transfer methods can greatly benefit from deuteration of the precursor molecule29 as a means 
to keep the nuclear spin system effectively constrained to just the three involved spins: the 
two nascent parahydrogens and the 13C nucleus.27 Lastly, because the hydrogenation reaction 
may be incomplete, both the precursor and product molecules should have relatively low in 
vivo toxicity. Meeting all these requirements represents the main disadvantage of PHIP, and 
only a limited number of potentially amenable precursor molecules and HCAs have qualified 
for in vivo use, so far. 
Those that have been successfully hyperpolarized and used for in vivo MRS include HP 
13C-succinate, which highlights metabolites of the TCA cycle30; 13C-tetrafluoropropyl 
propionate, for sensing lipids in atherosclerotic plaques,31 and 13C-phospholactate29 for 
preparation of HP 13C-lactate, which has been shown to be useful for in vivo metabolic 
imaging of elevated glycolysis in tumors. 
4.3 Homo- and Heterogeneous PHIP Catalysis 
4.3.1 Homogeneous Catalysis in Organic Solvents 
PHIP24, 25 has attracted the attention of those working in catalysis due to its promise to 
increase the NMR sensitivity of key low-concentration species. The PHIP process of pairwise 
para-H2 addition requires an efficient catalyst to complete the process within seconds (i.e. on 
the time-scale of relaxation processes). Initially, PHIP catalytic systems were based on 
Wilkinson’s catalyst RhCl(PPh3)3,24 Vaska’s complex Ir(CO)Cl(PPh3)2, and Crabtree’s 
catalyst [(COD)Ir(PCy3)(Py)]+PF6- , (COD = 1,4-cyclooctadiene, PCy3 = 
tricyclohexylphosphine, Py = pyridine). These transition metal-based systems catalyze the 
molecular hydrogenation reaction, where para-H2 is added to an unsaturated precursor via a 
molecular mechanism. Undergoing a molecular rather than a radical mechanism is essential 
for preserving the para-H2 spin order, which allows the observation of a PHIP effect.5, 24 A 
number of other transition metals and chelating ligands have been evaluated.5 In particular, 
implementation of bidentate ligands such as Ph2P(CH2)4PPh2 using Rh(I) as a catalyst has 
proven to be particularly effective for the ultrafast molecular addition of para-H2 to double 
and triple bonds, resulting in polarization enhancements of ~104 upon transfer to adjacent 13C 
nuclei.26 Despite the apparent synthetic success of this methodology, the approach has been 
limited to organic solvents, thus limiting biological applications where aqueous catalysts and 
substrates are desired. 
4.3.2 Homogeneous Aqueous Catalysis 
Chemical modification of phosphine-based ligands has permitted preparation of efficient 
water-soluble Rh(I)-based catalytic systems. By far, the most common variation utilizes 4-
bis[(phenyl-3-propanesulfonate) phosphine] butane di-sodium or its close variant,22 where 
Rh(I) is chelated by norbornadiene and two phosphines connected by a four- or three- carbon 
bridge.5 While aqueous homogeneous catalysts have opened the door to the first generation 
of mammalian in vivo imaging aided by PHIP30, 31, the presence of Rh(I) catalysts in the 
HCA solution is presently an obstacle to clinical applications. Replacement of homogeneous 
PHIP by heterogeneous PHIP (“HET-PHIP”) processes will likely be the key to PHIP clinical 
applications. HET-PHIP catalysis was extensively reviewed a few years ago,32 and is briefly 
discussed here in the context of recent advances and applications for aqueous media. 
4.3.3 Heterogeneous (Solid/Liquid) Catalysis 
A number of immobilized Rh complexes, based on either Wilkinson’s catalyst or closely 
related systems based on Rh(I) derived from [Rh(COD)2]+[BF4]-, have been evaluated for 
PHIP, typically using diphenylphosphinoethyl-modified silica as a stationary phase. While 
some PHIP signal was often observed, the enhancement values were generally low due to 
slow hydrogenation rates, loss of para-H2 polarization on the stationary phase surfaces, and 
chemical degradation of the catalyst. Alternatively, the application of transition metal 
nanoparticles is well-established for gas-solid PHIP (see below), and has been demonstrated 
for capped platinum nanoparticles33 in liquid-solid PHIP, where HP liquids are generated 
over solid-phase catalysts. Finally, Rh/TiO2 nanoparticles have also been used for PHIP 
processes, and PHIP hyperpolarization of acrylamide and allyl methyl in D2O solutions was 
demonstrated using these Rh/TiO2 nanoparticles. This approach is promising for in vivo 
applications in spite of the low P levels demonstrated to date. 
4.3.4 Heterogeneous (Solid/Gas) Catalysis 
A silica-embedded Wilkinson’s catalyst was also the first catalytic system enabling PHIP 
of gases at polarization levels sufficient for in vitro imaging.34 Further progress in this area 
has been driven by the development of more robust nanoparticle catalysts such as: Pt, Pd or 
Rh on TiO2, SiO2, Al2O3, or ZrO2 solid substrates. In general, better polarization transfer 
results were obtained with smaller nanoparticles: Rh and Pt provide superior results to Pd, 
while Al2O3 and especially TiO2 were superior performing substrates.32 
4.4 Hyperpolarization Instrumentation 
The controlled reaction of para-H2 with an unsaturated chemical precursor to produce a 
HCA takes place within an instrument referred to as a ‘PHIP hyperpolarizer’. The features 
and underlying polarization transfer technique differentiate the hyperpolarizers constructed to 
date.26, 35, 36 In general, inert gases such as N2 shuttle the precursor through a manifold during 
injection into a heated reactor wherein it is rapidly and thoroughly mixed with a para-H2 
atmosphere, as shown in Figure 5. Prior to injection, the precursor is typically pre-heated to 
further speed the chemical reaction of pair-wise addition. Two approaches to precursor/para-
H2 mixing have involved: (i) jet entrainment mixing;22 and more commonly (ii) spray mixing 
(Figure	5).26, 35, 36 Other differences in hyperpolarizer designs concern the method used to 
transfer the spin order of para-H2 after chemical synthesis to the heteronucleus which 
include: (i) field-cycling;26 or (ii) more efficiently,26, 35, 36 the application of RF pulses.27 In 
the latter method, RF pulses may be synchronized with the operation of the manifold by a 
LabView interface to a National Instruments data acquisition card,26, 35, 36 or by a low-field 
NMR spectrometer.36 In order to facilitate calibration of the RF pulse sequence parameters, 
and in situ NMR detection capability for the hyperpolarizer is desirable.36 The latter can 
result in a stand-alone PHIP hyperpolarizer with built-in quality assurance for the P 
produced. 
<Figure 5 near here> 
 
5. SIGNAL AMPLIFICATION BY REVERSIBLE EXCHANGE 
(SABRE) 
Another route to achieve hyperpolarization in solution is SABRE (Signal Amplification 
by Reversal Exchange), introduced by Duckett and co-workers in 2009.37 Similar to 
traditional PHIP, SABRE also takes advantage of the transfer of the spin order of para-H2 to 
a target substrate brought together by an organo-metallic catalyst. The key difference is that 
with SABRE, the transfer of spin order is not dependent upon the hydrogenation of an 
unsaturated bond of the substrate. This difference brings about two advantages: (i) the 
expansion of the range of applications of PHIP24, 25 with respect to the types of molecules that 
can serve as substrates; and (ii) that destruction or alteration of the original structure of those 
substrates is not required—one does not need to develop a precursor structure that will yield a 
desired agent upon hydrogenation. SABRE is the newest of the hyperpolarization techniques 
described in this Article, and consequently, its development for MRS/MRI is less advanced. 
It has some intrinsic advantages including simplicity, low cost, scalability, and the potential 
for continuous agent production, which are promising for biomedical applications. Indeed, it 
has already achieved substantial polarization enhancements in solution, with polarizations 
reaching ~10%.38-40 
In order for SABRE to work, the catalyst must transiently bind both the target substrate 
and the atoms of para-H2 with residence times that are long enough to allow the transfer of 
spin order or polarization to occur, but short enough to allow rapid turnover and subsequent 
accumulation of HP substrate in the solution. The process is illustrated in Figure 6. Although 
multiple organometallic complexes have been tested for SABRE, all to date use an iridium 
atom at the center—including the most successful SABRE catalyst, IrCl(COD)(IMes), where 
IMes = 1,3-bis(2,4,6-trimethyl-phenyl)imidazol-2-ylidene, and COD = cyclooctadiene. While 
the latter is not commercially available, its preparation is straightforward for those 
experienced with synthesis in inert-atmosphere environments.41 
<Figure 6 near here> 
As with many catalysts used in traditional PHIP, the basic iridium-based SABRE catalyst 
must first be activated before use. This typically involves dissolving the catalyst in an organic 
solvent along with excess substrate such as pyridine or a structural derivative: attempting to 
activate the catalyst without excess substrate can lead to irreversible de-activation of the 
catalyst.42 The solution is charged with para-H2, either by loading a few atm of para-H2 over 
the sample within a pressure-resistant vessel, or by continuously bubbling the para-H2 within 
a specially designed apparatus/tube, such as that depicted in Figure 7. Step-wise 
hydrogenation of the molecular COD-ring and binding of the H2 to the Ir leads to loss of the 
eight-carbon ring, and the formation of a six-coordinate site complex, with ligands 
comprising the IMes group, two hydrides, and three substrates, two of which are 
exchangeable. The progress of activation may be followed by observing changes in the 
characteristics of hydride resonances of transient species and the final activated structure.42 
<Figure 7 near here> 
SABRE experiments can be divided into two types: ex situ and in situ, depending on the 
location of the sample vessel during polarization transfer with respect to the MR magnet.  
The vast majority of SABRE experiments are performed ex situ: spin order is transferred via 
scalar couplings between the involved nuclear spins during the lifetime of the catalyst 
complex. The spin flips must be nearly energy-conserving: thus, the magnetic field must be 
sufficiently low to make the frequency difference between the hydride spins and the substrate 
spins similar to the scalar coupling between them. This corresponds to ~6 mT for 1H and 
~1µT for 15N.40. Thus the sample must be outside the MR magnet or within a fringe field for 
polarization transfer, and the sample rapidly moved to the magnet for detection. However, 
SABRE enhancements can also be observed in situ at high field.41 In this case, the 
mechanism appears to be mediated by dipolar cross-relaxation between the HP hydride spins 
and the substrate spins.41, 42 While much less efficient, in situ SABRE does not require 
sample shuttling. In addition, the application of RF pulse sequences, for example, to allow 
mixing of spin states by driving the spins into level anti-crossing regimes,43 may dramatically 
improve the efficiency of SABRE in situ. 
To date, only a limited number of HCAs have been hyperpolarized via SABRE. Besides 
pyridine (with 1H and 15N polarizations approaching ~10%38, 40), SABRE enhancements of 
amino acids and small peptides have been reported at low field.44 Most attention has been 
directed at biologically relevant pyridine derivatives. For example, 1H enhancements of ~230 
and ~1400 vs. conventional MRS were reported for the tuberculosis drugs isoniazid and 
pyrazinamide in deuterated methanol at 700 MHz, respectively corresponding to 1H P values 
(PH) of nearly ~1.3 and ~8%.39 Nicotinamide was used to demonstrate SABRE in pure water, 
albeit with a more modest enhancement of ~33 fold at 9.4 T,42 by first activating the catalyst 
in ethanol, drying it, and reconstituting it in an aqueous solution. 
Finally, in addition to the limitations imposed by the catalysts and substrates that are 
presently available and the need to perform SABRE in biologically compatible media, the 
catalysts themselves present an obstacle to the application of SABRE in the clinic. The 
catalysts are expensive and potentially toxic, making their recovery desirable after agent 
hyperpolarization. In this regard, following efforts of heterogeneous PHIP (“HET-PHIP”) by 
Koptyug and co-workers,32 “HET-SABRE” enhancement of pyridine using SABRE catalysts 
that were covalently immobilized onto solid substrates of microscale polymer beads has been 
achieved.45 Although the enhancements were small (~5-fold), the feasibility of creating 
separable catalysts for the creation of pure SABRE HP agents was demonstrated. 
6. SPIN-EXCHANGE OPTICAL PUMPING (SEOP) 
Hyperpolarization of noble gases via spin-exchange (SE) optical pumping (OP) was first 
demonstrated by Bouchiat et al. in 1960, following earlier pioneering work involving OP of 
alkali metal vapors by Kastler and others.46 Over time the technique has been refined with an 
aim to increase efficiencies of the OP and SE steps, as well as to reduce spin-relaxation or 
“spin-destruction” rates, to enable the production of HP gases with sufficiently high P in 
large enough quantities for NMR/MRI applications. Major technical advances in these areas 
came with the implementation of high-power laser diode arrays (LDAs)47 and the 
introduction of buffer gases and cell coatings.46 These improvements have contributed to 
increases in noble gas polarization, including values as high as ~90% for 129Xe (e.g., Ref. 48), 
upon which our discussion will focus. 
Although the complexity of SEOP setups may vary, one minimally needs: (i) an OP 
“cell” that contains the noble gas of interest (129Xe) and a small amount of alkali metal (Rb in 
the following discussion); (ii) a source of circularly polarized light resonant with the Rb 
electronic transition; (iii) a heater for the cell (to vaporize the Rb); and (iv) a magnetic field 
source. Circularly polarized laser light is used to optically pump Rb electrons into a selected 
spin state, as shown in Figure 8. A usually weak (~30 Gauss) magnetic field provides 
hyperfine Zeeman splitting of the Rb electronic energy states. Angular momentum is then 
transferred from the Rb electrons to the 129Xe nuclear spins (Figure 8b) via gas-phase 
collisions.46 Provided the OP/SE rates respectively exceed the electron and nuclear spin-
relaxation rates, 129Xe polarization can be increased far above thermal equilibrium according 
to49: 𝑃"#(𝑡&) = )*+γ*+,)- 𝑃./ (1 − 𝑒3 )*+3)- 45),   (1) 
where PXe and PRb represent the polarizations of xenon nuclei and rubidium electrons 
respectively, γse is the spin-exchange rate, γw is the rate of 129Xe spin destruction, and tp is 
the polarization time. Also present is N2 as a buffer gas, which at a pressure of ~100-200 Torr 
is sufficient to collisionally quench alkali metal fluorescence, thus avoiding re-emission of 
photons with random polarization that would otherwise decrease PRb.46, 50 One challenge for 
hyperpolarizing 129Xe is that most Rb/Xe collisions tend to depolarize Rb atoms without 
conserving spin angular momentum, making the Rb spin-destruction rate effectively 
proportional to the xenon nuclear density [Xe]—an issue that can be mitigated through the 
use of higher resonant laser fluxes (albeit with greater demands on thermal regulation50) 
and/or lower Xe partial pressures. Conducting SEOP for 129Xe at lower total cell pressures 
also enables more efficient spin exchange through three-body van der Waals collisions, in 
addition to the binary spin exchange that is dominant at higher gas pressures.51 On the other 
hand, higher cell pressures can broaden the Rb spectral lines resulting in more efficient 
absorption of the light.49 Finally, silicon coatings are often used to reduce Xe nuclear spin 
destruction, and all the components of the SEOP setup must be chosen to minimize exposure 
of the HP gas to paramagnetic centers, strong field gradients, and zero-crossings of the 
magnetic field. 
<Figure 8 near here> 
Many different polarizers have been developed to maximize the achievable polarization, 
PXe, and/or the rate of production of HP Xe. Their designs are typically grouped into two 
categories. First, in the continuous-flow (CF) method illustrated in Figure 9 49, 51, a xenon gas 
mixture is polarized as it passes continuously through the OP cell and is subsequently 
collected using a cryogenic “cold finger”,49 where it is stored at high field (>500 G) before it 
is carefully warmed52 to allow transfer to a secondary vessel with minimal losses of PXe. For 
example, Ruset et al. (Figure 9a) employed a number of features—including a Rb pre-
saturator upstream of a ~1.8 m optical cell, a high laser power (~90 W), a carefully designed 
optical path, and a relatively low Xe density and total pressure (allowing it to exploit the 
more efficient 3-body van der Waals spin-exchange interaction)—to attain a peak 129Xe 
polarization of ~67%, and a high output rate of 6 L Xe/h at %PXe=22%.51 
<Figure 9 near here> 
Second, the stopped-flow (SF) method (Figure 9b48, 53) takes place in a closed system 
where gas delivery, SEOP, and collection are performed sequentially. The cell is loaded with 
the desired gas mixture, and the gas is illuminated by the laser for ~10-30 min. until PXe nears 
a steady state. Prior to collection, the SEOP cell is cooled to condense the alkali metal vapor. 
The HP Xe can then be cryo-collected or simply expanded into another container (e.g. a 
Tedlar® bag). 
The second approach is simpler and easier to automate, and the reduction in 
magnetization density that results from HP gas dilution with buffer gas can be mitigated by 
using high [Xe] mixes.48 Nikolaou et al. recently presented an ‘open-source’ SF polarizer 
design (Figure 9b-d54) utilizing a 200 W narrowed  (~0.27 nm FWHM) LDA capable of 
attaining polarizations of ~90%, ~57%, ~50%, ~30%, for Xe partial pressures of ~300, ~500, 
~760, and ~1570 Torr backfilled with N2 to 2000 Torr, with a throughput of ~1 L/h.48 
Standard diagnostic techniques used in SEOP experiments include in situ low-field NMR 
spectroscopy to determine and control for PXe,, and near-infrared optical absorption 
spectroscopy to monitor pump laser wavelength, absorption profile, and inferred electronic 
PRb. While not strictly necessary for HP Xe preparation, additional diagnostic techniques 
such as: Faraday rotation;55 ESR46 to measure alkali metal density and spin polarization; and 
Raman spectroscopy to map elevated gas temperatures within the OP cell, have also been 
implemented to better understand the complex processes underlying mass, energy, and 
polarization transport within the SEOP apparatus. 
MRS applications of HP Xe typically exploit the extraordinary sensitivity of xenon’s 
chemical shift to its local molecular environment (Figure 8c).7 Of the two NMR-active xenon 
isotopes—129Xe (I=1/2) and 131Xe (I=3/2)—only 129Xe has sufficiently long relaxation times 
in condensed phases to allow MRS. Xenon’s highly polarizable electron cloud also allows it 
to participate in relatively substantial van der Waals interactions with proteins, lipid 
membranes, and living tissues. Xenon is not naturally found in the body in appreciable 
concentrations, which is both an advantage and a limitation: HP 129Xe spectra will be 
background-free, but achieving efficient HP Xe delivery to the body is key. Delivery options 
are: respiration and dissolution into the blood from the lungs; direct or intravenous injection 
of Xe-saturated solutions;7 or ex vivo gas dissolution into the blood or other solutions using 
off-the-shelf gas-exchange modules.56 
When Xe is dissolved in bodily tissues, a number of resonances corresponding to 
different cellular and tissue compartments may be observed generally within a range ~185-
215 ppm downfield from the gas reference at ~0 ppm.7 For example, the shift of 129Xe is so 
sensitive that its resonance in red blood cells responds to changes in blood oxygenation.57 
Functional studies of the brain are thus possible. The large 129Xe shift between xenon in the 
lung space and that dissolved in tissues may be exploited for a variety of pulmonary 
functional MRS/MRI studies, including studies of gas exchange efficiency in healthy versus 
pathological tissues. Nevertheless, without further intervention xenon’s concentration in the 
body is generally too low—and its interactions too weak and non-specific—for 129Xe MRS to 
provide much more in the way of specific biomolecular information. 
To overcome this low sensitivity and improve its specificity, HP 129Xe can be augmented 
with a host molecule, which can be functionalized to act as a biosensor as exemplified in 
Figure 10.58 The approach exploits the strong interaction between xenon and cryptophanes, 
which are molecules that can bind Xe atoms within their internal hydrophobic cavities. 
Indeed, cryptophanes are an excellent choice for the superstructure of xenon biosensors, not 
only because of their relatively high xenon affinity (Ka~103-104 M-1), but also because the 
exchange and relaxation timescales are compatible with MRS. Moreover, they can be 
chemically functionalized to facilitate both aqueous solubility and covalent linkage to a 
chosen functional group to target specific bioanalytes. In principle, almost any ligand or 
antibody can be used as a functional group for the purposes of biosensing,8 and multiple 
cages/biosensors could be simultaneously employed to allow multiplexed bioanalyte 
detection. The key feature empowering the biosensor approach is that the chemical shift of 
Xe within a biosensor cage that has bound a bioanalyte is measurably different from that of 
Xe residing within an unbound cage—thereby allowing the binding event to be detected via 
HP 129Xe MRS. It is expected that for in vivo applications, rather than delivering Xe-loaded 
biosensors to the body in a single bolus, one would first administer the biosensors to the 
subject and allow them time to bind to their biomolecular targets. Then later, HP Xe may be 
delivered (using an above method) so that it would have the opportunity to locate the 
biosensor cages immediately prior to MRS. 
<Figure 10 near here> 
This type of direct-detection experiment would yield three types of 129Xe peaks: one for 
unbound Xe in the bulk environment, one for Xe trapped in an unbound host biosensor 
molecule, and one for Xe residing in biosensor molecules bound to targeted analytes. 
However, if the targeted bioanalyte is in low concentration, the bound Xe signal can be 
buried in noise. One way around this problem is to employ HP chemical exchange saturation 
transfer, or Hyper-CEST.59 Hyper-CEST requires that the exchange of HP nuclei between 
sites is slow enough to give rise to unique, addressable resonances—yet fast enough to allow 
significant fractions of the populations to undergo exchange during the experiment.8 Thus, if 
a saturating RF pulse is applied at the frequency for a bound-Xe resonance, it will reduce the 
magnetization not only for the bound Xe pool, but also for the (typically much larger) bulk 
Xe pool as well: off-resonance saturation provides a control/reference signal. The greater 
sensitivity afforded by indirectly measuring the presence of activated biosensors via the more 
sensitive bulk-Xe signal allows detection of concentrations as low as ~100 nM, with further 
optimization not inconceivably improving the detection limit to the ~700 fM range.8 
 
7. CONCLUSIONS 
In summary, four hyperpolarization techniques have been described here in detail that 
either successfully enable in vivo MRS studies (d-DNP, PHIP, and SEOP/Xe), or have a 
strong potential for in vivo MRS in the near future (SABRE). Key features of these 
hyperpolarization methods from the perspective of their biomedical use are compared in 
Table 1. Some of these techniques have evolved rapidly from proof-of-principle studies using 
custom-built instrumentation to robust commercial equipment. This in turn has fueled reliable 
in vivo experimentation—including the first clinical trials in human volunteers. The ongoing 
innovations in instrumentation and the fundamental technology of hyperpolarization will 
likely continue to significantly and positively impact access and applications for the broader 
biomedical community, expanding the utility of HP methods as a new tool for probing 
fundamental biomedical questions. 
 
 
 
Table 1. Comparison of four hyperpolarization methods. 
Parameter d-DNP PHIP SABRE SEOP/Xe 
Wide range of agents yes no no no 
Straightforward scalability no yes yes yes 
High (>50% / order-unity) 
polarization yes yes no yes 
Moderately high (>1%) 
polarization yes yes yes yes 
Continuous generation no yes yes yes 
Different modes of 
production, i.e. continuous 
(C) vs. batch (B)/stopped-
flow (SF)) B/SF C & B/SF C & B/SF C & B/SF 
Preparation of 'pure' agents yes 
under 
development 
under 
development yes 
Preparation of concentrated 
agent suitable for in vivo 
MRS use yes yes no yes 
Long-lived in vitro agent 
(relaxation time > 1 min) yes yes no yes 
Long-lived in vivo agent 
(relaxation time > 0.5 min) yes yes no no 
Technology Cost high low low medium 
Operational Cost high low low medium 
Commercially available 
device yes/multiple 
no (but yes 
for para-H2 
generator) yes yes 
Phase of agent gas/liq/solid  liq/gas liq gas 
Environment Sensing (ES) 
and penetration of 
biochemical pathways (BP) BP BP & ES - ES 
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Figure Captions 
 
Figure 1. Effects of DNP conditions on electronic and nuclear spins. (a). Effects of 
temperature on 13C (dashed black curve) and electron (e-, solid black curve) spin 
polarizations at 5 T, along with electronic T1 relaxation time (T1,e, gray solid curve) at 0.35 T. 
The figure is reprinted with permission from A. Comment and M. E. Merritt, Biochemistry, 
2014, 53, 7333.9 Copyright 2014 American Chemical Society. (b) The response of a two-
electron nuclear spin system during the DNP process: microwave irradiation (hwe1) induces 
spin-flips of coupled electrons (left), which then cross-relax with nearby nuclei (top right), 
driving the nuclear spins into the same HP spin state (bottom right). (c) Example of a 
microwave sweep used to calibrate the optimal excitation frequency for 13C DNP. (d) 
Examplary buildup and decay of 13C polarization over time with the DNP microwave source 
engaged (increasing curve) and turned-off (decreasing curve). Parts (c) & (d) are from 
Ardenkjaer-Larsen, et al. PNAS 100.18 (2003) 10158-10163; Copyright (2003) National 
Academy of Sciences, U.S.A.1 
 Figure 2. Overview of the d-DNP process. Within the high magnetic field of the DNP 
polarizer, high-power microwaves excite free electrons in free radical species mixed with the 
HP substrate and frozen into an amorphous solid. The electrons undergo spin-exchange with 
nearby 13C nuclei and over time, the entire sample becomes polarized via direct dipole-dipole 
interactions as well as nuclear spin diffusion involving the 1H nuclei present in the HP 
substrate or glassing agent. After polarization, the HCA sample is rapidly dissolved in hot 
solvent and shuttled into the MR scanner room, for injection into the animal or human 
subject. 
 Figure 3. Production of para-hydrogen (para-H2). (a) H2 passes over a paramagnetic 
catalyst which rapidly increases the para-H2 fraction to the thermodynamic equilibrium at the 
given cryogenic temperature. (b) Production typically involves a “parahydrogen generator” 
built around a two-stage He cryocooled cold-head involving pressure gauges (PG), manual 
valves (MV), gas pressure regulators (R), and automated valves (AV). 
 
 
 Figure 4. Schematics of para-H2 pairwise addition in PHIP. (a) Symmetry breaking of 
nascent para-hydrogen’s nuclear spin state via chemical reaction creates a non-symmetric 
product. (b) para-H2 state symmetry-breaking through chemical reaction with pairwise 
addition followed by polarization transfer to 13C, produces a HP contrast agent comprised of 
a 13C HP carboxyl moiety with a long T1 lifetime. 
 
 
 
 
 
 
 
 
 
 Figure 5. Generic PHIP hyperpolarizer schematic. Optional elements are boxes with 
dotted lines. In the PHIP hyperpolarization cycle: (i) para-H2 is filled in the previously 
deoxygenated (via extensive N2 gas venting) heated reactor, (ii) “tracer PHIP precursor and 
catalyst” solution is loaded into an optional “Heater” element followed by (iii) rapid solution 
spraying in the para-H2-filled reactor under conditions of 1H decoupling; (iv) when the 
spraying is finished (a few seconds), the polarization transfer sequence immediately 
transforms (< 1 second) hyperpolarization from nascent parahydrogen protons (see Figure 
4b) to hyperpolarization on the 13C nucleus; (v) the solution containing the 13C HP compound 
is ejected from the reactor through an optional purification stage for in vivo administration. 
The system can be purged with N2 gas (typically ~1 min) to remove any residual solution 
from the PTFE lines to prepare for the next PHIP hyperpolarization production cycle. 						
 Figure 6. Schematic of the SABRE process. Reversible exchange of para-H2 and the 
substrate on a metal catalyst ([M]) leads to a HP substrate. The figure is adapted from Ref. 6. 
 
 
Figure 7. Experimental setup for SABRE. Para-H2 bubbles through a catalytic solution in 
a conventional 5 mm NMR tube. The solution sits in a medium-wall-thickness NMR tube 
where para-H2 is delivered via Teflon® tubing, and the expended gas leaves via an exhaust 
line that can be capped with a pressure-calibrated safety valve to allow SABRE at elevated 
para-H2 pressure. The figure is reprinted with permission from M. L. Truong, et al., J. Phys. 
Chem. B, 2014, 18, 13882.42 Copyright 2014 American Chemical Society. 
 
 
 
 Figure 8. SEOP hyperpolarization and chemical-shift sensitivity of 129Xe. (a) Application 
of circularly polarized laser light and subsequent non-radiative relaxation results in depletion 
of one Rb electron (mj) level and accrual of population in the other, rendering the Rb 
electronically spin-polarized (Rb nuclear spin levels not shown).  (b) Gas-phase collisions 
allow spin-exchange between Rb electrons and 129Xe nuclei, resulting in HP 129Xe with time. 
A three-body collision is shown in this example, with N2 molecules facilitating formation and 
break-up of the complex. (c) Chemical shifts for 129Xe in different environments. Figures are 
reprinted from Nuclear magnetic resonance of laser-polarized noble gases in molecules, 
materials, and organisms. B. M. Goodson, J. Magn. Reson. 2002, 155, 157, Copyright 
(2002),7 with permission from Elsevier. 
 
 Figure 9. Examples of 129Xe hyperpolarizers. (a). Diagram showing the CF design of Ruset 
et al. 51. Figure courtesy of W. Hersman, reprinted with permission from I. C. Ruset, S. Ketel, 
F. W. Hersman, Phys. Rev. Lett. 2006, 96, 053002. Copyright (2006) by the American 
Physical Society. (b-d). Our Consortium’s second-generation SF Xe hyperpolarizer. The 
photo in (b) shows the principal components of the device [(1) laser; (2) 3D-printed oven; (3) 
Xe gas supply; (4) microcontroller box; (5) power supplies; (6) low-frequency NMR 
spectrometer; (7) water chiller; (8) vacuum pumps; (9) electromagnetic coils].  Diagrams 
showing the oven/optical path and gas manifold are shown respectively in (c) and (d). Figure 
d is reprinted with permission from P. Nikolaou, et al., Anal. Chem., 2014, 86, 8206.54 
Copyright 2014 American Chemical Society. 
 
 Figure 10. Structure and MR of a xenon biosensor. The chemical structure of a xenon 
biosensor molecule comprises a cryptophane cage, a linker group, and a molecule (e.g. 
biotin) to bind to a targeted bioanalyte (e.g. avidin) with high affinity and specificity.58 Below 
the structure are 129Xe spectra monitoring the binding of biotin-functionalized xenon to the 
prototypical bioanalyte avidin. The spectra show only the cryptophane-bound peaks; the 
(much larger) peak corresponding to free xenon in water is at 193 ppm.  The spectra differ by 
the absence (top) and presence (bottom) of 80 nmol avidin in solution, manifesting in the 
bottom spectrum by the appearance of a new peak at ~72.5 ppm. Adapted from figures 
courtesy of Prof. Alex Pines. 
 
